1Mogi M, Otogoto J, Ota N, et aI. Interleukin-ll3, inter- leukin-6, t2-mierogtobulin, and transforming growth facror-ain gingival crevicuIar fluid from human perio- dontal disease[J]. Arch Oralbol, I999,44(6) : 535.
2Delmas PD. Biochemical markers of bonetumour: meth- odology and clinical use in osteoporosis [J]. AJM, I989,9I (Supply 58) :59-63.
2Crofton PM,Wade JC,Taylor MRH.Serum concentrations of carboxyl-terminal propeptide of type I procollagen amino-terminal propetide of type HI procollagen cross-linked carboxyl-terminal propeptide of type I collagen,and their interrelationship in school children[J].Clin Chem,2008,43(9): 1577.
4Takagi M,Kasayama S,Yamamoto T, et al.Advanced glycosylation endproducts stimulate tumor necrosis factor production by human bone-derived cells[J].J Bone Miner Res,2007,19(7):439.
5中华医学会.骨质疏松症和骨矿盐疾病分册[M].北京:人民卫生出版社,2008:1-3.
6Mazzaglia P J,Berber E, Kovach A, et al. The changingpresenta-tion of hyperparathyroidism over 3 decades [ J]. Arch Surg,2008,143(3) :260-266.
7Sadat-Ali M, Sultan 0,Al-Turki H, et al. Does high serum iron lev-el induce low bone mass in sickle cell anemia [ J]. Biometals,2011,24(1) : 19-22.
